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ASBMT ADOPTS POLICY ON CORD
BLOOD REGISTRIES
A single, integrated system is pre-
ferred for registering units of umbili-
cal cord blood, according to policy
that has been adopted by ASBMT
leaders.
The policy action anticipates a re-
port from the Institute of Medicine on
establishing a national cord blood
stem cell program. The policy is based
on 10 principles:
● The needs and interests of pa-
tients must be paramount in the
development of any cord blood
registry.
● Patients and transplant clinicians
can be best served by a central-
ized, international registry that
provides a seamless, timely, and
economical means of matching
and obtaining donor cells.
● The collection, processing, test-
ing, typing, storage, matching,
and dissemination of cord blood
units should be part of a contin-
uum of cell sources accessible for
transplant. Cells from all sour-
ces—marrow, peripheral blood,
and cord blood—should be
readily and equally accessible.
● The methods and mechanisms
for search and procurement of
cells within an integrated cord
blood registry must be valid, reli-
able, efficient, and transparent.
● An integrated cord blood registry
should promote the collection of
units that are racially and ethni-
cally diverse.
● Cord blood banks participating in
an integrated registry should
maintain high standards for
product efficacy and patient
safety, as determined and con-
firmed through accreditation.
● An integrated cord blood registry
should ensure confidentiality of
all donor and patient records.
● Governmental funding is essen-
tial for the support of an inte-
grated registry for umbilical cord
blood.
● An integrated cord blood registry
should provide professional and
public education about its opera-
tions and all phases of donation,
processing, storage, search, and
procurement.
● An integrated cord blood registry
should have a quality improve-
ment program and support re-
search to enhance the efficacy,
efficiency, and economy of its
operations.
NEW INVESTIGATORS WIN BBMT
EDITORIAL AWARDS
Two medical scientists are the re-
cipients of new investigator editorial
awards, based on their articles pub-
lished this past year in Biology of
Blood and Marrow Transplantation.
● Recipient of the George Santos
Award for best clinical science
article is Jeffrey Davies of Royal
Free & University College Medical
School, London
● Recipient of the Ernest McCulloch
& James Till Award for best basic
science article is Swati Choksi,
PhD, of the National Institutes of
Health, Bethesda, Md.
The annual awards, each including
a $5,000 prize, are supported by ed-
ucational grants from StemCell Tech-
nologies, Inc., and StemSoft Soft-
ware, Inc., Vancouver. They were
presented by Robert Korngold, PhD,
editor of the journal, and Gary
Racine, general manager of StemSoft
Software, at the 2005 Tandem BMT
Meetings in Keystone, Colo.
Dr. Choksi’s winning article was “A
CD8 DE Loop Peptide Analog Pre-
vents GvHD in a Multiple Minor His-
tocompatibility Antigen-Mismatched
Bone Marrow Transplantation Model,”
which appeared in BBMT Volume 10,
Number 10.
The Davies winning article was “An-
tiviral Immunity and T-Regulatory Cell
Function Are Retained after Selective
Alloreactive T-Cell Depletion in Both the
HLA-Identical and HLA-Mismatched Set-
tings,” which appeared in BBMT Vol-
ume 10, Number 4.
Recipients of the two annual
awards can be not more than five
years past a graduate or post-doctoral
program or a clinical research fellow-
ship, or currently active in a training
program as a clinical resident or fel-
low, post-doctoral fellow, medical
student, graduate student or under-
graduate student.
The judging committee is the BBMT
Editorial Board and ASBMT Publica-
tions Committee.
LIFETIME ACHIEVEMENT AWARD
PRESENTED TO RICHARD O’REILLY
The chair of the Department of Pe-
diatrics at Memorial Sloan-Kettering
Cancer Center and past-president of
the American Society for Blood and
Marrow Transplantation has been
named recipient of the 2005 ASBMT
Lifetime Achievement Award.
Richard J. O’Reilly, MD, received
the recognition at the President’s Din-
ner at the 2005 Tandem BMT Meet-
ings in Keystone, Colo. The annual
award is supported by a grant from
Pfizer Inc.
A graduate of the College of Holy
Cross in Worcester, Mass., Dr. O’Reilly
earned his medical degree at the Uni-
versity of Rochester School of Medi-
cine in Rochester, N.Y. He was a pe-
diatrics intern at the University of
Minnesota Hospitals, Minneapolis, a
resident at Children’s Hospital Medi-
cal Center, Boston, and a fellow in
infectious disease at Children’s Hospi-
tal Medical Center and Beth Israel
Hospital, also in Boston.
Dr. O’Reilly joined the staff at Me-
morial Sloan-Kettering in 1984. He is
a professor of immunology and pedi-
atrics at Cornell University School of
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Medical Sciences. For nearly 20 years
he held the Vincent Astor Chair of
Clinical Research at Memorial Sloan-
Kettering. He currently holds the
Claire L. Tow Chair in Pediatric Oncol-
ogy Research.
Dr. O’Reilly was one of the found-
ing members of ASBMT and served as
secretary of its first Board of Directors.
He was a founding co-editor-in-chief
of Biology of Blood and Marrow
Transplantation, from 1995 to 2000.
He was elected by the ASBMT mem-
bership to serve as president in 2001-
2002.
Dr. O’Reilly was among those in-
strumental in conceiving and launch-
ing the Foundation for the Accredita-
tion of Cellular Therapy (FACT), the
voluntary accrediting agency for
blood and marrow transplant cen-
ters.
TASK FORCE WILL ADDRESS
QUALITY IN CLINICAL OUTCOMES
A task force will propose methods
by which ASBMT and the Foundation
for Accreditation of Cellular Therapy
(FACT) can develop measurements of
quality in treatment outcomes in he-
matopoietic stem cell transplant pro-
grams.
Appointed by the ASBMT Executive
Committee, the panel is chaired by
Claudio Anasetti, MD, and includes
John DiPersio, MD, PhD, Roy Jones,
MD, PhD, and Samuel Silver, MD,
PhD.
The quality assessment initiative is
based on recommendations from the
BMT Center Medical Directors Confer-
ence that looked at the status of mea-
surements of quality in clinical out-
comes in February in Keystone.
BEST ABSTRACTS CHOSEN FROM
RECORD 349 SUBMITTED
A record 349 abstracts from 33
countries were submitted for the Tan-
dem BMT Meetings in Keystone, Colo.
The abstract review committees se-
lected six for awards.
Winning the ASBMT Best Abstract
Award for Outstanding Basic Science
Research were:
● Klaus Muller, MD, PhD, DMSc,
Rigshospitalet, Copenhagen,
Denmark
● Francesco Dazzi, MD, PhD, Ham-
mersmith Hospital, London,
United Kingdom
● Jerry Stein, MD, Schneider Chil-
dren’s Medical Center, Petach
Tikva, Israel
Winning the CIBMTR Best Abstract
Awards for Clinical Research were:
● Renate Arnold, MD, Charite Uni-
versity Hospital Berlin, Berlin,
Germany
● Jonathan D. Wofford, MPH, Car-
dinal Glennon Children’s Hospi-
tal, St. Louis, Mo.
● Joanne Kurtzberg, MD, Duke
University Medical Center,
Durham, N.C.
The ASBMT and CIBMTR best ab-
stract awards are supported by unre-
stricted educational grants from
Pfizer.
ABSTRACTS POSTED ONLINE
Abstracts presented at the 2005
Tandem BMT Meetings were pub-
lished in the February 2005 issue of
Biology of Blood and Marrow Trans-
plantation (Vol. 11, No. 2, Supple-
ment 1). They also can be viewed
online at the ASBMT Web site
www.abstracts2view.com/bmt.
2005 TANDEM BMT MEETINGS
AUDIOCASSETTES AVAILABLE
Audiocassettes can be purchased
for all plenary and concurrent scien-
tific sessions, workshops and oral ab-
stract sessions held at the Tandem
BMT Meetings this past February in
Keystone.
Also available are presentations in
the conferences of the transplant
nurses, BMT pharmacists, clinical re-
search associates and BMT center ad-
ministrators.
Information and online purchase
are at www.CMEunlimited.org/bmt.
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